Please login to the form below

Not currently logged in
Email:
Password:

Celyad appoints Dr David Gilham as R&D vice president

He will resign from the company’s advisory board to fulfill his new role

Celyad Dr David GilhamBelgian biopharmaceutical company Celyad has selected Dr David Gilham to be its new vice president of research and development.

Currently a member of Celyad's immuno-oncology scientific advisory board, Dr Gilham will resign from his post in August to fulfill his new role from 1 September.

Dr Gilham brings extensive experience in the field of CAR-T cells, with his research activity focused on engineering T-cells for cancer therapies and pre-clinical study development. 

Before joining Celyad Dr Gilham was a Reader in the Institute of Cancer Sciences at the University of Manchester, and led the Manchester Cancer Research Centre's clinical and experimental immunotherapy group.

Dr Gilham said: “I am truly excited to be joining Celyad at such an important time in its history.

“Engineering immune system T-cells to attack and eradicate cancer is at the leading edge of cancer research and I look forward to advancing Celyad's unique portfolio of cell therapy candidates in the clinic.”

16th June 2016

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics